Silicon Valley Bank Provides $26.5MM Term Loan Agreement to Savara
Savara, a clinical stage biopharmaceutical company focused on rare respiratory diseases, entered into a term loan agreement of $26.5 million with Silicon Valley Bank to replace its existing credit facility with the bank.